183 related articles for article (PubMed ID: 30938524)
1. Design, Synthesis, and Pharmacokinetic Evaluation of Phosphate and Amino Acid Ester Prodrugs for Improving the Oral Bioavailability of the HIV-1 Protease Inhibitor Atazanavir.
A M Subbaiah M; Mandlekar S; Desikan S; Ramar T; Subramani L; Annadurai M; Desai SD; Sinha S; Jenkins SM; Krystal MR; Subramanian M; Sridhar S; Padmanabhan S; Bhutani P; Arla R; Singh S; Sinha J; Thakur M; Kadow JF; Meanwell NA
J Med Chem; 2019 Apr; 62(7):3553-3574. PubMed ID: 30938524
[TBL] [Abstract][Full Text] [Related]
2. (Carbonyl)oxyalkyl linker-based amino acid prodrugs of the HIV-1 protease inhibitor atazanavir that enhance oral bioavailability and plasma trough concentration.
Subbaiah MAM; Ramar T; Subramani L; Desai SD; Sinha S; Mandlekar S; Jenkins SM; Krystal MR; Subramanian M; Sridhar S; Padmanabhan S; Bhutani P; Arla R; Kadow JF; Meanwell NA
Eur J Med Chem; 2020 Dec; 207():112749. PubMed ID: 33065417
[TBL] [Abstract][Full Text] [Related]
3. Development of water-soluble prodrugs of the HIV-1 protease inhibitor KNI-727: importance of the conversion time for higher gastrointestinal absorption of prodrugs based on spontaneous chemical cleavage.
Sohma Y; Hayashi Y; Ito T; Matsumoto H; Kimura T; Kiso Y
J Med Chem; 2003 Sep; 46(19):4124-35. PubMed ID: 12954064
[TBL] [Abstract][Full Text] [Related]
4. Coupling of an Acyl Migration Prodrug Strategy with Bio-activation To Improve Oral Delivery of the HIV-1 Protease Inhibitor Atazanavir.
Subbaiah MAM; Meanwell NA; Kadow JF; Subramani L; Annadurai M; Ramar T; Desai SD; Sinha S; Subramanian M; Mandlekar S; Sridhar S; Padmanabhan S; Bhutani P; Arla R; Jenkins SM; Krystal MR; Wang C; Sarabu R
J Med Chem; 2018 May; 61(9):4176-4188. PubMed ID: 29693401
[TBL] [Abstract][Full Text] [Related]
5. Propylene glycol-linked amino acid/dipeptide diester prodrugs of oleanolic acid for PepT1-mediated transport: synthesis, intestinal permeability, and pharmacokinetics.
Cao F; Gao Y; Wang M; Fang L; Ping Q
Mol Pharm; 2013 Apr; 10(4):1378-87. PubMed ID: 23339520
[TBL] [Abstract][Full Text] [Related]
6. Intestinal absorption and activation of decitabine amino acid ester prodrugs mediated by peptide transporter PEPT1 and enterocyte enzymes.
Tao W; Zhao D; Sun M; Wang Z; Lin B; Bao Y; Li Y; He Z; Sun Y; Sun J
Int J Pharm; 2018 Apr; 541(1-2):64-71. PubMed ID: 29471144
[TBL] [Abstract][Full Text] [Related]
7. Atazanavir-loaded Eudragit RL 100 nanoparticles to improve oral bioavailability: optimization and in vitro/in vivo appraisal.
Singh G; Pai RS
Drug Deliv; 2016; 23(2):532-9. PubMed ID: 24963752
[TBL] [Abstract][Full Text] [Related]
8. Advances and challenges in PBPK modeling--Analysis of factors contributing to the oral absorption of atazanavir, a poorly soluble weak base.
Berlin M; Ruff A; Kesisoglou F; Xu W; Wang MH; Dressman JB
Eur J Pharm Biopharm; 2015 Jun; 93():267-80. PubMed ID: 25872159
[TBL] [Abstract][Full Text] [Related]
9. Improving Drug Delivery While Tailoring Prodrug Activation to Modulate
A M Subbaiah M; Subramani L; Ramar T; Desai S; Sinha S; Mandlekar S; Kadow JF; Jenkins S; Krystal M; Subramanian M; Sridhar S; Padmanabhan S; Bhutani P; Arla R; Meanwell NA
J Med Chem; 2022 Aug; 65(16):11150-11176. PubMed ID: 35952307
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, chemical and enzymatic hydrolysis, and bioavailability evaluation in rabbits of metronidazole amino acid ester prodrugs with enhanced water solubility.
Mahfouz NM; Hassan MA
J Pharm Pharmacol; 2001 Jun; 53(6):841-8. PubMed ID: 11428660
[TBL] [Abstract][Full Text] [Related]
11. Peptide prodrugs: improved oral absorption of lopinavir, a HIV protease inhibitor.
Agarwal S; Boddu SH; Jain R; Samanta S; Pal D; Mitra AK
Int J Pharm; 2008 Jul; 359(1-2):7-14. PubMed ID: 18455890
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of amino acid ester prodrugs of acyclovir after oral administration: interaction with the transporters on Caco-2 cells.
Katragadda S; Jain R; Kwatra D; Hariharan S; Mitra AK
Int J Pharm; 2008 Oct; 362(1-2):93-101. PubMed ID: 18638532
[TBL] [Abstract][Full Text] [Related]
13. Intestinal absorption of novel-dipeptide prodrugs of saquinavir in rats.
Jain R; Duvvuri S; Kansara V; Mandava NK; Mitra AK
Int J Pharm; 2007 May; 336(2):233-40. PubMed ID: 17207946
[TBL] [Abstract][Full Text] [Related]
14. Ethylene glycol-linked amino acid diester prodrugs of oleanolic acid for PepT1-mediated transport: synthesis, intestinal permeability and pharmacokinetics.
Cao F; Jia J; Yin Z; Gao Y; Sha L; Lai Y; Ping Q; Zhang Y
Mol Pharm; 2012 Aug; 9(8):2127-35. PubMed ID: 22352697
[TBL] [Abstract][Full Text] [Related]
15. Novel approaches for designing 5'-O-ester prodrugs of 3'-azido-2', 3'-dideoxythymidine (AZT).
Parang K; Wiebe LI; Knaus EE
Curr Med Chem; 2000 Oct; 7(10):995-1039. PubMed ID: 10911016
[TBL] [Abstract][Full Text] [Related]
16. Water-soluble prodrugs of dipeptide HIV protease inhibitors based on O-->N intramolecular acyl migration: Design, synthesis and kinetic study.
Hamada Y; Matsumoto H; Yamaguchi S; Kimura T; Hayashi Y; Kiso Y
Bioorg Med Chem; 2004 Jan; 12(1):159-70. PubMed ID: 14697781
[TBL] [Abstract][Full Text] [Related]
17. Water-soluble prodrugs of the human immunodeficiency virus protease inhibitors lopinavir and ritonavir.
DeGoey DA; Grampovnik DJ; Flosi WJ; Marsh KC; Wang XC; Klein LL; McDaniel KF; Liu Y; Long MA; Kati WM; Molla A; Kempf DJ
J Med Chem; 2009 May; 52(9):2964-70. PubMed ID: 19348416
[TBL] [Abstract][Full Text] [Related]
18. Dipeptide derivatives of AZT: synthesis, chemical stability, activation in human plasma, hPEPT1 affinity, and antiviral activity.
Santos C; Morais J; Gouveia L; de Clercq E; Pannecouque C; Nielsen CU; Steffansen B; Moreira R; Gomes P
ChemMedChem; 2008 Jun; 3(6):970-8. PubMed ID: 18389514
[TBL] [Abstract][Full Text] [Related]
19. Prodrugs of HIV protease inhibitors-saquinavir, indinavir and nelfinavir-derived from diglycerides or amino acids: synthesis, stability and anti-HIV activity.
Gaucher B; Rouquayrol M; Roche D; Greiner J; Aubertin AM; Vierling P
Org Biomol Chem; 2004 Feb; 2(3):345-57. PubMed ID: 14747863
[TBL] [Abstract][Full Text] [Related]
20. Controlled drug release: new water-soluble prodrugs of an HIV protease inhibitor.
Matsumoto H; Sohma Y; Kimura T; Hayashi Y; Kiso Y
Bioorg Med Chem Lett; 2001 Feb; 11(4):605-9. PubMed ID: 11229781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
